By Topic

Meeka Metals (ASX: MEK) Tests Major Support: Can the Downtrend Stabilise?

Apr 26, 2026

Proactive Equities Team

Meeka Metals faces selling pressure near key support after a volatile year, amid operational challenges and cautious sentiment. As it transitions to production at Murchison, investors are watching whether support holds or signals further downside despite long-term growth potential.

Is Orthocell's (ASX: OCC) Recent Share Price Decline a Warning Sign or a Buying Signal?

Apr 25, 2026

Proactive Equities Team

Orthocell is a regenerative medicine company expanding Remplir globally, but investors remain cautious because revenue growth is uneven, the business is still loss-making, and U.S. uptake may take time, leaving the stock a higher-risk turnaround opportunity.

Treasury Wine Estates (ASX: TWE): What could be the next upside target for the company's share?

Apr 25, 2026

Proactive Equities Team

Treasury Wine Estates shows early reversal signs after a downturn, supported by restructuring optimism and stabilising demand. Key upside lies around A$5.30–A$5.70, with further gains possible if momentum holds, though sustained strength is needed to confirm a broader recovery.

Why Cochlear's (ASX: COH) share price keeps crashing, and where can it find a bottom?

Apr 24, 2026

Proactive Equities Team

Cochlear’s share price slump reflects profit downgrades, slowing growth, weak global demand, and macro pressures. The stock is down sharply, but a lasting bottom likely depends on stabilising earnings and clearer signs of demand recovery.

SportsHero's (SHO) share price on the move again. How much higher will it go this time?

Apr 22, 2026

Proactive Equities Team

SportsHero (ASX: SHO) is up over 300%, driven by deals and funding, but is now consolidating after a sharp rally, with further upside dependent on holding support.

PlaySide Studios (ASX: PLY) Strategic Pivot: Where can its share price go after the recent volatility?

Apr 22, 2026

Proactive Equities Team

PlaySide Studios is shifting from contract development to original IP and publishing to boost margins and growth. Strong partnerships and a solid pipeline support optimism, but revenue volatility and past unprofitability keep investor sentiment cautious.

1...61 62 63...80

Page 62 of 80

...

1...61 62 63...80

Page 62 of 80